Dr David Randerson, Acuity's Managing Director, specializes in the valuation of intangible assets, and business entities whose main assets are intangibles, with particular expertise in intellectual property.
David has experience with valuing pharmaceuticals, stem cells, medical devices, diagnostics, agriculture, biochemical and cell culture technologies and environmental products. In the fields of physical and applied sciences, he has valued software, internet, electronics, telecommunications, mining and petrochemical projects, process engineering, production engineering and automotive technologies. Valuations have been performed for purposes of licensing, capital raising and investment, sale, depreciation and amortisation, impairment, purchase price allocation, consolidation, mergers, acquisitions, stock options and goodwill. Research-in-process is of particular
interest to David.
David has a Bachelor of Chemical Engineering (Monash University), Master of Science in Applied Science (UNSW) and a Doctorate of Philosophy in Biomedical Engineering (UNSW). He is a fellow of the Australian Institute of Company Directors and a member of the Institution of Chemical Engineers. David considers his engineering and biomedical expertise as essential prerequisites for the types of analyses
he performs.